Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
MicroRNA Market Forecast: What Market Value Is Expected By 2030?
The microRNA market experienced significant expansion recently, projecting a rise from $1.57 billion in 2025 to $1.86 billion by 2026, propelled by an 18.5% compound annual growth rate. This upward trajectory during the previous period was underpinned by several key factors: the escalating embrace of genomic research, a heightened need for identifying biomarkers, the proliferation of PCR-based testing methodologies, the broadening scope of cancer research initiatives, and the increasing deployment of next-generation sequencing (NGS) instruments.
Anticipate a swift expansion for the microrna market over the coming years, projecting a valuation of $3.32 billion by 2030, fueled by a compound annual growth rate (CAGR) of 15.6%. This anticipated surge is propelled by a confluence of factors, including the broadening clinical utility of microrna diagnostics, an elevated adoption of personalized medicine approaches, advancements in therapeutic microrna development, intensified research into infectious diseases, and augmented investments in molecular assay technologies. Key developments shaping this forecast period encompass the strides in precision genomics, the integration of artificial intelligence into microrna expression analysis, the increasing reliance on cloud-based solutions for sequencing data storage, the push towards automation within molecular diagnostics, and the incorporation of internet of things (IoT) technology to streamline laboratory workflows.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15608&type=smp
MicroRNA Market Growth Momentum: Which Factors Are Influencing Demand?
The escalating incidence of cancer is anticipated to be a primary catalyst for the expansion of the microRNA market. Cancer, a multifaceted condition marked by aberrant cell multiplication and spread, frequently results in tumors that can infiltrate adjacent tissues and metastasize to distant sites, presenting substantial health hazards. This rise in cancer diagnoses can be attributed to several factors, such as an aging global population, lifestyle habits including tobacco use and unhealthy eating, exposure to environmental toxins, and enhanced diagnostic capabilities facilitating earlier detection. MicroRNAs are integrated with established cancer treatments to amplify therapeutic efficacy and improve patient prognoses. Furthermore, these small RNA molecules function as valuable diagnostic and prognostic indicators, aiding in the classification of cancers, forecasting disease trajectories, and assessing the effectiveness of interventions. Illustratively, data from the National Cancer Institute, a prominent US governmental body, indicated that in May 2024, approximately 20 million new cancer cases and 9.7 million fatalities linked to the disease were reported globally in 2022, with projections suggesting an increase to 15.3 million deaths and 29.9 million new cases annually by 2040. Consequently, the growing prevalence of cancer is fueling the advancement of the microRNA market.
MicroRNA Market Segments: Where Are The Largest Growth Opportunities?
The microrna market covered in this report is segmented –
1) By Product: Instruments, Consumables
2) By Assay Type: Immunoassay, Next Generation Sequencing, MiRNA Arrays, Polymerase Chain Reaction (PCR) Based Arrays
3) By Application: Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Other Applications
4) By End User: Academic And Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Clinical Research Organizations
Subsegments:
1) By Instruments: Quantitative PCR Systems, Microarray Platforms, Next-Generation Sequencing (NGS) Systems, Real-Time PCR Instruments, Microrna Analyzers
2) By Consumables: MicroRNA Kits ( Extraction Kits, Detection Kits), PCR Reagents, Primers And Probes, Microarrays And Chips, RNA Sequencing Kits
MicroRNA Market Trends Reshaping Industry Growth
Leading entities within the microRNA sector are concentrating their efforts on pioneering sophisticated offerings, including bespoke miRNA probe design, to precisely cater to the requirements of the scientific and medical communities, thereby boosting the precision of miRNA identification and enabling a broad spectrum of uses. These tailored miRNA probe services involve expert assistance from companies in the biotech and molecular biology fields, aimed at creating and manufacturing unique probes that target specific microRNAs for different research and clinical purposes. As an illustration, in September of 2023, Abnova Corporation, a biotechnology firm headquartered in Taiwan, introduced upgraded capabilities for creating custom miRNA probes, complemented by an expanded collection of pre-made miRNA probes, to address the varied demands of academic institutions, industrial partners, and research groups involved in microRNA studies. Such probes are instrumental in the accurate discernment and pinpointing of miRNAs, which are diminutive, non-coding RNA segments essential for numerous biological functions. Abnova’s personalized probe services guarantee superior specificity and reduced instances of unintended interactions, rendering them highly effective for the examination of biological material with scarce miRNA quantities.
MicroRNA Market Major Participants And Competitive Dynamics
Major companies operating in the microrna market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Miltenyi Biotec, LGC Limited, Promega Corporation, Abcam plc, Integrated DNA Technologies Inc., NanoString Technologies Inc., Horizon Discovery Ltd., OriGene Technologies Inc., Omega Bio-Tek, New England Biolabs, Quantabio, SeqMatic LLC, GeneCopoeia Inc., HTG Molecular Diagnostics Inc.
Access The Complete MicroRNA Market Report:
https://www.thebusinessresearchcompany.com/report/microrna-global-market-report
MicroRNA Market Regional Distribution: Which Areas Drive Market Expansion?
North Americawas the largest region in the microRNA market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the microrna market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
